Skye Bioscience, Inc. Unrealized Gain (Loss) on Derivatives
Skye Bioscience, Inc. (SKYE) reported Unrealized Gain (Loss) on Derivatives of $59.41 thousand for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:UnrealizedGainLossOnDerivatives · last filed 2022-11-14
- Skye Bioscience, Inc. unrealized gain (loss) on derivatives for the quarter ending 2022-09-30 was $6.23K, a 96.72% decline year-over-year.
- Skye Bioscience, Inc. unrealized gain (loss) on derivatives for the quarter ending 2022-06-30 was $9.52K.
- Skye Bioscience, Inc. unrealized gain (loss) on derivatives for the quarter ending 2022-03-31 was $43.66K.
- Skye Bioscience, Inc. unrealized gain (loss) on derivatives for the quarter ending 2021-09-30 was $189.65K, a 55.29% decline year-over-year.
| Period end | Unrealized Gain (Loss) on Derivatives 3 month | Unrealized Gain (Loss) on Derivatives 6 month | Unrealized Gain (Loss) on Derivatives 9 month |
|---|---|---|---|
| 2022-09-30 | $6.23K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $15.75K derived: sum of 2 quarters · filed 2022-11-14 | $59.41K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $9.52K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $53.18K 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $43.66K 10-Q · filed 2022-05-06 | ||
| 2021-09-30 | $189.65K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $69.00K derived: sum of 2 quarters · filed 2022-11-14 | -$169.35K 10-Q · filed 2022-11-14 |
| 2021-06-30 | -$120.65K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | -$359.00K 10-Q · filed 2022-08-15 | |
| 2021-03-31 | -$238.35K 10-Q · filed 2022-05-06 | ||
| 2020-09-30 | $424.14K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $433.69K 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $9.55K 10-Q · filed 2021-08-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |